Lead Product(s) : Norepinephrine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
NuLiv's Verbasnol Reduces Acne And Improves Skin Quality in Study
Details : Norepinephrine is an adrenergic receptor agonist, small molecule drug candidate. Diluted with sodium chloride solution the treatment of severe, acute hypotension.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 22, 2024
Lead Product(s) : Norepinephrine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Norepinephrine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I/ Phase II
Sponsor : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 06, 2012
Lead Product(s) : Norepinephrine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I/ Phase II
Sponsor : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Norepinephrine
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 07, 2011
Lead Product(s) : Norepinephrine
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Norepinephrine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I
Sponsor : University of Wisconsin, Madison
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 20, 2010
Lead Product(s) : Norepinephrine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I
Sponsor : University of Wisconsin, Madison
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
